OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
April 02, 2023
The ROSS Model CDA-200 is fitted with multiple agitators for semi-continuous operation.
The Thermo Fisher Scientific Nicolet Summit X FTIR Spectrometer is a high-performance system designed for flexibility, ease of use, and high productivity.
Bio-Rad Laboratories StarBright Blue and StarBright Yellow dyes are conjugated to flow validated antibodies, supporting flow cytometry panel design in immunology design.
Decreasing vein to vein time saves lives.
March 30, 2023
CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.
Takeda plans to build a new facility in Osaka, Japan, for the manufacture of plasma-derived therapies.
March 28, 2023
Webinar Date/Time: Tue, Apr 25, 2023 11:00 AM EDT
March 24, 2023
Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.
March 21, 2023
Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.